Bispecific Antibody drugs gained popularity since approval of blinatumomab. 6 bsAb drugs are approved by the US FDA/EMA & 180+ are in clinical trials.
Popular Targets for Bispecific Antibody Drugs

Bispecific Antibody drugs gained popularity since approval of blinatumomab. 6 bsAb drugs are approved by the US FDA/EMA & 180+ are in clinical trials.
Therapeutic antibodies dominate pipelines and top selling drugs at major pharmaceutical companies. They have proven to be valuable tools in the fight against diseases from cancer and autoimmune disorders to infectious and neurodegenerative diseases. Beyond therapeutics, monoclonal antibodies shown to
Metabolism Assays from Elabscience Elabscience metabolism assay kits have a complete set of indicators and a wide range of applications, including Enzymes, Oxidative stress, Liver & Renal Function, Amino acids & proteins, Glycolysis & Lipid Metabolism, Lipids metabolism, Plant Physiology
Extremolytes such as Ectoine, Hydroxyectoine, Glucosylglycerol and BioStab solutions for biomolecule stabilisation offered by AdipoGen Life Sciences.
AdipoGen’s SARS-CoV-2 Spike Protein (D614G) (Stable Trimer) (rec.) (His) is a full-length soluble SARS-CoV-2 Spike protein.
Expressing recombinant antibodies can be done in all kinds of systems. Many different cell lines can be used for expressing antibodies, including mammalian cells like HEK293 or CHO, or even yeast, plant or insect cell lines. Each expression system has
The three most common methods to develop recombinant antibodies include display systems, direct B-cell cloning, or the use of pre-existing hybridomas.
AdipoGen Life Sciences has developed a sensitive, specific, and fast SARS-CoV-2 Neutralising Antibodies Detection Kit.
Immunogens and Carrier Proteins What is an immunogen? An immunogen is a specific type of antigen that is able to elicit an immune response. Antibody development is dependent on a humoral immune response mediated by immune cells recognising a molecule
ProSci’s roots lie in the research of the Human Immunodeficiency Virus and working to develop a neutralising vaccine against it. Below is an “abstract of abstracts” summarising the research performed over the last several years that has built their business